Addex Therapeutics Ltd
SIX:ADXN
Addex Therapeutics Ltd
SIX:ADXN
Price:
0.1155 CHF
0.43%
Market Closed
Updated:
Apr 29, 2024
Addex Therapeutics Ltd
Cash from Financing Activities
|
Addex Therapeutics Ltd
Cash from Financing Activities Peer Comparison
Comparables:
ADCT
CRSP
BSLN
IDIA
KURN
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Addex Therapeutics Ltd
SIX:ADXN
|
Cash from Financing Activities
CHf5.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Cash from Financing Activities
$73.9m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Cash from Financing Activities
$62.7m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Cash from Financing Activities
-CHf57.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-57%
|
CAGR 10-Years
-20%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Cash from Financing Activities
CHf162.3m
|
CAGR 3-Years
396%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Cash from Financing Activities
-CHf171k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Addex Therapeutics Ltd's Cash from Financing Activities?
Cash from Financing Activities
5.2m
CHF
5.2m
CHF
Based on the financial report for Sep 30, 2023, Addex Therapeutics Ltd's Cash from Financing Activities amounts to 5.2m CHF.
What is Addex Therapeutics Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-55%
-55%
Over the last year, the Cash from Financing Activities growth was -55%.
You don't have any saved screeners yet
